Mark Guerin
Director of Finance/CFO at TRAWS PHARMA, INC.
Net worth: 36 336 $ as of 2024-03-30
Profile
Mark P.
Guerin is currently the Chief Financial Officer at Traws Pharma, Inc. He previously worked as the Director of Financial Reporting & Internal Controls at Barrier Therapeutics, Inc. and as the Chief Financial Officer & Vice President of Finance at CardioKine, Inc. Mr. Guerin obtained his undergraduate degree from DeSales University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TRAWS PHARMA, INC.
0.17% | 2024-03-13 | 35,976 ( 0.17% ) | 36 336 $ | 2024-03-30 |
Mark Guerin active positions
| Companies | Position | Start |
|---|---|---|
| TRAWS PHARMA, INC. | Director of Finance/CFO | 2016-02-11 |
Former positions of Mark Guerin
| Companies | Position | End |
|---|---|---|
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Director of Finance/CFO | 2011-11-30 |
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Corporate Officer/Principal | - |
Training of Mark Guerin
| DeSales University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
- Stock Market
- Insiders
- Mark Guerin
